Evidence map›Paper›PMID 25855180›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2015

Abnormal excitability and episodic low-frequency oscillations in the cerebral cortex of the tottering mouse.

Samuel W Cramer, Laurentiu S Popa, Russell E Carter, Gang Chen, Timothy J Ebner

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Samuel W CramerDepartment of Neuroscience, University of Minnesota, Minneapolis, Minnesota 55455.ORCID http://orcid.org/0000-0002-7103-4182
Laurentiu S PopaDepartment of Neuroscience, University of Minnesota, Minneapolis, Minnesota 55455.
Russell E CarterDepartment of Neuroscience, University of Minnesota, Minneapolis, Minnesota 55455.
Gang ChenDepartment of Neuroscience, University of Minnesota, Minneapolis, Minnesota 55455.
Timothy J EbnerDepartment of Neuroscience, University of Minnesota, Minneapolis, Minnesota 55455 ebner001@umn.edu.
University of Minnesota · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM008244 · NIGMS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI SHIMIZU, YOJI · 1988 to 2024
$13.6M
PREDOCTORAL TRAINING OF NEUROSCIENTISTST32GM008471 · NIGMS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI EBNER, TIMOTHY J · 1993 to 2017
$4.9M
ROLE OF THE CEREBELLUM IN VISUALLY GUIDED ARM MOVEMENTSR01NS018338 · NINDS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI EBNER, TIMOTHY J · 1985 to 2020
$4.7M
NINDS Center Core at the University of MinnesotaP30NS062158 · NINDS · UNIVERSITY OF MINNESOTA · PI EBNER, TIMOTHY · 2011 to 2015
$3.5M
Optogenetic modulation of episodic dystonia in the tottering mouseF31NS080338 · NINDS · UNIVERSITY OF MINNESOTA · PI CRAMER, SAMUEL W. · 2012 to 2013
$58k
NIGMS NIH HHS T32 GM008244NIGMS NIH HHS T32 GM008471NINDS NIH HHS F31 NS080338NINDS NIH HHS P30 NS062158NINDS NIH HHS R01 NS018338NINDS NIH HHS R01 NS18338
6 · The paper itself

Abstract

The Ca(2+) channelopathies caused by mutations of the CACNA1A gene that encodes the pore-forming subunit of the human Cav2.1 (P/Q-type) voltage-gated Ca(2+) channel include episodic ataxia type 2 (EA2). Although, in EA2 the emphasis has been on cerebellar dysfunction, patients also exhibit episodic, nonmotoric abnormalities involving the cerebral cortex. This study demonstrates episodic, low-frequency oscillations (LFOs) throughout the cerebral cortex of tottering (tg/tg) mice, a widely used model of EA2. Ranging between 0.035 and 0.11 Hz, the LFOs in tg/tg mice can spontaneously develop very high power, referred to as a high-power state. The LFOs in tg/tg mice are mediated in part by neuronal activity as tetrodotoxin decreases the oscillations and cortical neuron discharge contain the same low frequencies. The high-power state involves compensatory mechanisms because acutely decreasing P/Q-type Ca(2+) channel function in either wild-type (WT) or tg/tg mice does not induce the high-power state. In contrast, blocking l-type Ca(2+) channels, known to be upregulated in tg/tg mice, reduces the high-power state. Intriguingly, basal excitatory glutamatergic neurotransmission constrains the high-power state because blocking ionotropic or metabotropic glutamate receptors results in high-power LFOs in tg/tg but not WT mice. The high-power LFOs are decreased markedly by acetazolamide and 4-aminopyridine, the primary treatments for EA2, suggesting disease relevance. Together, these results demonstrate that the high-power LFOs in the tg/tg cerebral cortex represent a highly abnormal excitability state that may underlie noncerebellar symptoms that characterize CACNA1A mutations.

Indexed as

4-AminopyridineAcetazolamideAnimalsBenzeneacetamidesCalcium Channels, N-TypeCerebral CortexChannelopathiesCortical SynchronizationDisease Models, AnimalEnzyme InhibitorsFemaleMaleMiceMice, TransgenicMutationNeurotransmitter Agents2-(4-(2-methylpyridin-4-yl)phenyl)-N-(4-(pyridin-3-yl)phenyl)acetamide4-AminopyridineAcetazolamideBenzeneacetamidesCalcium Channels, N-TypeEnzyme InhibitorsFG 9041Neurotransmitter AgentsNG-Nitroarginine Methyl EsterNitric Oxide Synthase Type IIIPotassium Channel BlockersPyridinesQuinoxalinescalcium channelopathycerebral cortexepisodic ataxia type 2episodic nervous system dysfunctionflavoprotein optical imagingtottering mouse

Identifiers

PMID25855180
PMCPMC4388925
OpenAlexW2074317967

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.